Viatris has grown revenue −1.9% a year over three years and −1.1% a year over five. Revenue growth, 3-year annual rate: −1.9% (Drug Manufacturers - Specialty & Generic median +15%). Revenue growth, 5-year rate: −1.1%, growth has slowed since the five-year average. Years of annual history on file: 8, FY2018 to FY2025, as filed.

VTRSViatris

HealthcareUSD

$16.86

$9.0352 weeks$17.87

Is it growing?

Is VTRS growing?

Viatris has grown revenue −1.9% a year over three years and −1.1% a year over five.

−1.9%

Revenue growth, 3-year annual rate · Drug Manufacturers - Specialty & Generic median +15% · shrinking · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: −1.1%
Revenue growth, 5-year rate · −1.9% over three · growth has slowed since the five-year average
Years of annual history on file: 8
Years of annual history on file · FY2018 to FY2025, as filed

Details›